Pharmacy shelf information: Chronic disease management in the value space of pharmacies

u003cpu003eu003c/pu003eu003cpu003eText: Chen Xiaofangu003c/pu003eu003cpu003eAt the 2016 China Chronic Disease Conference, Liang Xiaofeng, deputy director of the Chinese Center for Disease Control and Prevention, introduced that by 2030, Chinese residents will have chronic non-communicable diseases The morbidity and mortality rate will decline, but due to factors such as the aging population and the declining number of patients suffering from infectious diseases, the proportion of deaths caused by chronic diseases in the total deaths will increase from the current 86% to 90%. The prevention and control of chronic diseases has a long way to go. Liang Xiaofeng pointed out that multi-party cooperation is necessary to effectively curb the chronic disease blowout situation. Retail pharmacies and community medical institutions are the closest to chronic diseases and high-risk groups. They have their own advantages and should play a huge role in the entire chronic disease prevention and control system. However, the embarrassing reality reminds pharmacies that although dreams are necessary, they also need to be down to earth. . u003c/pu003eu003cpu003eu003c/pu003eu003cpu003eIn the past two years, it has gradually become a consensus that retail pharmacies in my country take 'drugs for chronic diseases' as the core to undertake prescription outflow dividends from public hospitals. Under the current situation of extensive chronic disease management in my country, it is becoming inevitable to mobilize social resources to jointly improve the quality and efficiency of chronic disease management. Therefore, in recent years, retail pharmacies in my country have continued to explore and summarize chronic disease management, hoping to explore a model that can be replicated. However, for the time being, due to multiple subjective and objective reasons, pharmacies still need to pay more perseverance and patience on this road. u003c/pu003eu003cpu003eIf you only look at this time node in 2017, when pharmacies continue to explore the management of chronic diseases, they may need to consider multiple factors:u003c/pu003eu003cpu003eFirst, re-understand chronic disease management Value space for pharmaciesu003c/pu003eu003cpu003eReal clarification of the space for chronic disease management in pharmacies. According to the 'China's Chronic Disease Prevention and Control Work Plan (2012~2015)' issued by the National Health and Family Planning Commission, the goal of China's chronic disease prevention and control is to 'further improve the nationwide chronic disease prevention and control service network and comprehensive prevention and control work mechanism, and establish chronic disease monitoring and information management. System, improve the ability of chronic disease prevention and control, strive to build a social support environment, implement departmental responsibilities, reduce the level of risk factors for chronic diseases of the population, reduce premature death and disability, and control the level of socioeconomic burden caused by chronic diseases.'u003c/pu003eu003cpu003e Combining the concept of chronic disease management, chronic disease management refers to the medical behavior and process of regular detection, continuous monitoring, evaluation, and comprehensive intervention management of chronic non-communicable diseases and their risk factors. The main connotations include early screening of chronic diseases and chronic diseases. Disease risk prediction, early warning and comprehensive intervention, as well as the comprehensive management of chronic disease population, and the evaluation of chronic disease management effects. Judging from the current publicly published research reports on chronic disease management practices, the targets of chronic disease management are not only “chronic non-communicable diseases”, but also include the “cognition, behavior, and motivation of patients with chronic non-communicable diseases” and high-risk groups. '. u003c/pu003eu003cpu003eu003c/pu003eu003cpu003eCombining the above, what is the value space of pharmacies? Where should the pharmacy’s entry point be located in the entire chain of chronic disease management? u003c/pu003eu003cpu003eStart from reality, or have more room for development in the 'cognition, behavior, and motivation' of high-risk groups and patients with chronic diseases. u003c/pu003eu003cpu003eWu Xiaozhi, general manager of Zhixing United One (Shenzhen) Investment Management Co., Ltd., once pointed out that many chronic disease management in pharmacies are stuck in the 'detection' stage, but one step further will lose confidence. He believes that instead of grabbing unorganized eyebrows and beards, pharmacies should give full play to their own advantages. For example, they should find ways to provide customers with more health services in traditional Chinese medicine and traditional Chinese medicine. Through traditional Chinese medicine health care education, they can improve their trust and stickiness. Determine your own direction on detection and comprehensive intervention. u003c/pu003eu003cpu003eSecondly, go all out to enhance the professional foundation. u003c/pu003eu003cpu003eIt is necessary to face the current weak situation of professional talents in retail pharmacies in my country, combine chronic disease management and talent construction in accordance with the actual situation of the company, and improve the professionalism of talents in the exploration of the model, and use the professionalism of talents to support the model. u003c/pu003eu003cpu003eFrom the current situation, taking licensed pharmacists as an example, according to the data from the Certified Pharmacist Certification Center of the State Food and Drug Administration, currently in the retail pharmacies in 31 provinces and autonomous regions (excluding Hong Kong, Macao and Taiwan), licensed pharmacists There are still less than 10 provinces with 1 store and 1 person. Regardless of the professional quality of the licensed pharmacist, at least it can be used as a representative symbol of pharmacy professionals. The equipment is still such that it shows that the talent specialization of pharmacies is still facing huge challenge. u003c/pu003eu003cpu003eu003c/pu003eu003cpu003eTherefore, the combing of the talent system, the establishment of the incentive assessment system, and the adjustment of the mechanism of talent introduction and training will all be important for pharmacies that intend to fully enter the field of chronic disease management. It is the core issue that cannot be avoided in 2017. u003c/pu003eu003cpu003eAgain, platform-based thinking, and actively connecting multiple resourcesu003c/pu003eu003cpu003eIt is true that before pharmacies cut into the big opportunity of chronic disease management, the most direct response comes from upstream medical equipment companies, and the most intuitive The result comes from the transformation of prescription drug companies. u003c/pu003eu003cpu003eTake the Chinese Pharmaceutical Retail Business Club as an example. In 2016 alone, it is reported that foreign (joint)-funded and domestic-funded prescription drug companies have had three strategic meetings and discussions with them, in frequent and high-level exchanges. Behind the scenes, the trend of cooperation in 2017 is ready to emerge. In the exchange, the actions of Zhengda Tianqing, a leading company in the field of liver health in my country, are quite representative. Its president Wang Shanchun said that in 2017, it plans to select more than 170 cities across the country to expand community hospital resources, choose to cooperate with chain pharmacies capable of accepting prescription drugs, and use chronic disease drugs as an entry point to jointly promote the sales of prescription drugs. u003c/pu003e